Lineage Cell Therapeutics (LCTX) Asset Utilization Ratio (2011 - 2026)
Lineage Cell Therapeutics' (LCTX) Asset Utilization Ratio was 0.12 for Q2 2026, up 12.5% from 0.11 a year earlier but down 8.9% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Lineage Cell Therapeutics was 0.13, up 45.4% from FY2024.
- By year, Asset Utilization Ratio came in at 0.09 in FY2024 (+11.4%), 0.08 in FY2023 (-19.3%), 0.10 in FY2022 (+220.9%) and 0.03 in FY2021 (+96.4%).
- Five-year quarterly Asset Utilization Ratio spans a low of 0.03 in Q3 2021 and a high of 0.14 in Q4 2025.
- Year over year, Asset Utilization Ratio has now increased in each of the last eight quarters, with growth averaging 34.2% over the last eight quarters.
- The high point for year-over-year Asset Utilization Ratio in five years was Q2 2022 (growth of 577.4%); the low point was Q2 2024 (a decline of 37.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.13 (Q1 2026), 0.14 (Q4 2025) and 0.12 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 0.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.12 |
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.14 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.09 |
| Mar 31, 2023 | 0.10 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.10 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.03 |
API Access
Lineage Cell Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();